$TLF

TANDY LEATHER FACTORY INC (TLF): Results of Operations and Financial Condition

TANDY LEATHER FACTORY INC (TLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0000909724 0000909724 2026-08-11 2026-08-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported:) August 11, 20

Original reporting
Published Aug 11, 2026, 8:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$TLF
Neutral
low confidence
Mentioned
$TLF
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TLFNeutralLow
01

Why it matters

The filing itself is a procedural confirmation of an earnings release, but the provided text does not disclose the results, guidance, or any material changes.

02

Market read

Traders may use this as a timestamp for when Q2 results were released, but the text does not contain the decision-relevant numbers.

03

What to watch

The market impact will depend on the specific Q2 metrics and any forward-looking statements in Exhibit 99.1, which are not included in the provided text.

Relevance 7/10Novelty 2/10Timing: Filed Aug 11, 2026 after-hours, tied to Q2 FY2026 results release.

Background

The article is an SEC Form 8-K (Item 2.02) indicating Tandy Leather Factory issued a press release and filed its quarterly 10-Q for Q2 FY2026.

Company-level read

Ticker impact

$TLFNeutralLow confidence
Context

TLF filed an 8-K stating it issued a press release and filed its Q2 FY2026 10-Q results under Item 2.02.

Expected impact

Near-term price reaction is possible on the underlying Q2 results, but this article text provides no figures to assess direction.

Evidence & confidence

The 8-K confirms the company released and filed its quarterly results, yet the provided body contains only procedural details and no performance metrics, outlook, or risk items.

Market effects

No sector read-through is provided because the text lacks any margin, demand, or inventory commentary.

None stated.

None stated.

Counterpoint

Because the scraped content omits the actual 10-Q/press-release figures, traders should not infer fundamentals or direction from the filing alone.

Key entities

  • Tandy Leather Factory, Inc.

    Nasdaq-listed issuer that filed an 8-K for Q2 FY2026 results under Item 2.02.

  • SEC Form 8-K

    Current report used to announce quarterly results and attach Exhibit 99.1.

Related articles

$MLYSMedAI 8/10

Why is Mineralys Therapeutics stock sliding today?

Investing.com reports Mineralys Therapeutics (MLYS) shares fell 4.9% in after-hours after posting a Q2 2026 per-share loss of $2.85 versus a $2.63 analyst consensus. The loss followed a rise in operating costs, including $221.4 million R&D and a $200 million upfront payment to Tanabe for lorundrostat royalty buyout. FDA PDUFA is Dec. 22, 2026.

$IAUMed

i-80 Gold Q2 Earnings Call Highlights

i-80 Gold (TSE:IAU) reported Q2 cash of about $465M (down from $514M in Q1) and Q2 revenue just over $24M. Gold production was ~11,100 oz with ~5,300 oz sold. Management said Granite Creek resource work supports a feasibility study expected in Q3 2026, while Archimedes feasibility is delayed to mid-2027; Lone Tree refurbishment remains on track for first gold by end-2027.

$INUVMed

Inuvo, Inc. (INUV): Results of Operations and Financial Condition

Inuvo, Inc. (INUV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 4 inuvo_ex991.htm PRESS RELEASE inuvo_ex991.htm EXHIBIT 99.1 Inuvo Reports Second Quarter 2026 Results Audience Modeling Revenue Grows 19% as Company Streamlines Legacy Search and Strengthens Capital Position Management to host conference call at 4:15 PM ET, Tuesday, Augu

$SNALMedAI 9/10

Why is Snail stock plummeting today?

Investing.com reports Snail Inc. (SNAL) shares fell 30.9% in after-hours to $3.17 after Q2 2026 results missed expectations. Revenue was $19.7M, down 11.3% YoY and below a ~$29M consensus. Bookings fell 19.6% to $21.8M and net loss was $3.0M. The sell-off was company-specific.

$RDVTMed

Red Violet, Inc. (RDVT): Results of Operations and Financial Condition

Red Violet, Inc. (RDVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rdvt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 red violet Reports Second Quarter 2026 Financial Results Record Revenue of $26.7 Million, an Increase of 23%; Record Cash Flow from Operations of $10.6 Million BOCA RATON, Fla. – August 10, 2026 – Red Violet, Inc. (NASDAQ: RD